Works matching IS 20474873 AND DT 2021 AND VI 28 AND IP 1

Results: 21
    1

    Intensity of statin treatment after acute coronary syndrome, residual risk, and its modification by alirocumab: insights from the ODYSSEYOUTCOMES trial.

    Published in:
    European Journal of Preventive Cardiology, 2021, v. 28, n. 1, p. 33, doi. 10.1177/2047487320941987
    By:
    • Diaz, Rafael;
    • Li, Qian H.;
    • Bhatt, Deepak L.;
    • Bittner, Vera A.;
    • Baccara-Dinet, Marie T.;
    • Goodman, Shaun G.;
    • Jukema, J. Wouter;
    • Takeshi Kimura;
    • Parkhomenko, Alexander;
    • Pordy, Robert;
    • Reiner;, Željko;
    • Roe, Matthew T.;
    • Szarek, Michael;
    • Hung-Fat Tse;
    • White, Harvey D.;
    • Zahger, Doron;
    • Zeiher, Andreas M.;
    • Schwartz, Gregory G.;
    • Steg, Ph Gabriel
    Publication type:
    Article
    2

    Eligibility for PCSK9 inhibitors based on the 2019 ESC/EAS and 2018 ACC/AHA guidelines.

    Published in:
    European Journal of Preventive Cardiology, 2021, v. 28, n. 1, p. 59, doi. 10.1177/2047487320940102
    By:
    • Koskinas, Konstantinos C.;
    • Gencer, Baris;
    • Nanchen, David;
    • Branca, Mattia;
    • Carballo, David;
    • Klingenberg, Roland;
    • Blum, Manuel R.;
    • Carballo, Sebastian;
    • Muller, Olivier;
    • Matter, Christian M.;
    • Lu¨scher, Thomas F.;
    • Rodondi, Nicolas;
    • Dik Heg;
    • Wilhelm, Matthias;
    • Ra¨ber, Lorenz;
    • Mach, Franc¸ois;
    • Windecker, Stephan
    Publication type:
    Article
    3
    4
    5
    6
    7
    8

    The need for PCSK9 inhibitors and associated treatment costs according to the 2019 ESC dyslipidaemia guidelines vs. the risk-based allocation algorithmof the 2017 ESC consensus statement: a simulation study in a contemporary CAD cohort.

    Published in:
    European Journal of Preventive Cardiology, 2021, v. 28, n. 1, p. 47, doi. 10.1093/eurjpc/zwaa088
    By:
    • Blaum, Christopher;
    • Seiffert, Moritz;
    • Goßling, Alina;
    • Kro¨ger, Friederike;
    • Bay, Benjamin;
    • Lorenz, Thiess;
    • Braetz, Julian;
    • Graef, Annika;
    • Zeller, Tanja;
    • Schnabel, Renate;
    • Clemmensen, Peter;
    • Westermann, Dirk;
    • Blankenberg, Stefan;
    • Brunner, Fabian J.;
    • Waldeyer, Christoph
    Publication type:
    Article
    9
    10
    11
    12
    13
    14
    15
    16
    17
    18
    19

    Long-termopiate use and risk of cardiovascular mortality: results fromthe Golestan Cohort Study.

    Published in:
    European Journal of Preventive Cardiology, 2021, v. 28, n. 1, p. 98, doi. 10.1093/eurjpc/zwaa006
    By:
    • Nalini, Mahdi;
    • Shakeri, Ramin;
    • Poustchi, Hossein;
    • Pourshams, Akram;
    • Etemadi, Arash;
    • Islami, Farhad;
    • Khoshnia, Masoud;
    • Gharavi, Abdolsamad;
    • Roshandel, Gholamreza;
    • Khademi, Hooman;
    • Zahedi, Mahdi;
    • Abedi-Ardekani, Behnoush;
    • Vedanthan, Rajesh;
    • Boffetta, Paolo;
    • Dawsey, Sanford M.;
    • Pharaoh, Paul D.;
    • Sotoudeh, Masoud;
    • Abnet, Christian C.;
    • Day, Nicholas E.;
    • Brennan, Paul
    Publication type:
    Article
    20
    21